In human ischemic heart disease, Zc3h12a is dramatically elevated, and transgenic overexpression of Zc3h12a in mouse heart protects against inflammation‐induced NF‐κB activation.[80] Niu et al. The gene discussed is NFKB1; the disease is coronary artery disorder.